Murdoch et al. in 1977 called Down syndrome an "atheroma-free model." In this preliminary study, we investigated advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in 47 age-matched Down syndrome patients and 20 age-matched healthy controls. In these healthy patients, we detected no new biochemical risk factors for atherosclerosis, such as AOPP and hs-CRP, so risks are probably considerably lower.
Advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in an atheroma-free model : Down's syndrome / G. Goi, C. Baquero-Herrera, F. Licastro, G. Dogliotti, M.M. Corsi. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 0167-5273. - 113:3(2006 Nov 18), pp. 427-429. [10.1016/j.ijcard.2005.10.019]
Advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in an atheroma-free model : Down's syndrome
G. GoiPrimo
;C. Baquero-HerreraSecondo
;G. DogliottiPenultimo
;M.M. CorsiUltimo
2006
Abstract
Murdoch et al. in 1977 called Down syndrome an "atheroma-free model." In this preliminary study, we investigated advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in 47 age-matched Down syndrome patients and 20 age-matched healthy controls. In these healthy patients, we detected no new biochemical risk factors for atherosclerosis, such as AOPP and hs-CRP, so risks are probably considerably lower.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
